Unlisted shares promise fast money, but two buzzing threads lay out a cautionary tale. In Post 1, the message is blunt: 'Please don't buy unlisted shares.' A real-world misstep with CSK stock underscores the risk, with the price wandering long after a big run. Trading happens across brokers; you can buy via Precize or StakeHub and even a promoter-backed route via Onix handling Gensol unlisted shares; the path to a sale is tedious.
• Precize or StakeHub make unlisted trades, but selling is a lengthy, tedious process [1]. • Most unlisted IPOs have given negative listings this year [1]. • GMP pricing sits pre-listing, but the true price is set by the market [1].
Post 2 argues a sharper case for listed markets: they price in fundamentals more reliably, and unlisted quotes can have math quirks. If the quoted numbers are right, some claims show 245% gains instead of 125% [2]. A post even flags criticism of a Tata Group headline, arguing listed valuations can be fair while unlisted bets hurt retail investors [2].
• The listed route enforces discipline; unlisted bets invite mispricings and trap retail buyers [2]. • Math errors in unlisted quotes, and the possibility that listing prices diverge from actual market-cleared prices, are cautions raised in these discussions [2].
Bottom line: the discipline, transparency, and price discovery of listed markets often outshine the flashy but riskier unlisted path. Watch how price, fundamentals, and liquidity line up in official listings next. [1][2]
References
Please don't buy unlisted shares.
Discusses unlisted shares, brokers, GMP, listing gains, and IPO timing; questions on Tata Capital, NSE unlisted, and trading processes.
View sourceA reason why I like listed markets more than unlisted. Chutiya retail investors ka hi kat ta hai end me
Critiques unlisted market valuations; praises listed market pricing; blames retail investors; notes possible math error in quoted numbers.
View source